CCL5 and fatty liver disease: In vitro, lipid-overloaded hepatocytes were shown to produce CCL5, which activated the fibrogenic activity of immortalized primary human HSCs (LX-2) [154], and, vice versa, activated HSCs secreted CCL5, which deteriorated hepatic steatosis [155].